Navigation Links
Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
Date:5/1/2012

SAN DIEGO, May 1, 2012 /PRNewswire/ -- Pfenex Inc. today announced that the Department of Health and Human Services (HHS), through the Biomedical Advanced Research and Development Authority (BARDA), has exercised its option associated with the existing Pfenex contractual relationship begun in July, 2010. This extends the contract supporting the development of a robust Pfēnex Expression Technology™ based production strain and process for the production of bulk recombinant protective antigen (rPA) from anthrax. Pursuant to the contract, Pfenex will continue to develop an rPA-based anthrax vaccine from rPA produced in Pseudomonas fluorescens.  During the contract's base period, Pfenex demonstrated that a strongly immunogenic, stable and protective form of rPA could be expressed and recovered from the highly efficient fermentation of a strain of P. fluorescens engineered to produce rPA.

"We are pleased with the results and progress provided by Pfenex's recombinant platform technology to the production of a next generation anthrax vaccine," stated Bertrand C. Liang, Chief Executive Officer. "The exercise of this option by BARDA enables Pfenex and BARDA to continue our successful partnership sharing a common objective to develop an anthrax vaccine with a process capable of achieving the goals of the Strategic National Stockpile for the U.S. Government, including production, shelf life, and administration improvements."

About Pfenex Inc.

Pfenex Inc. is a protein production company leveraging the unique and powerful Pfenex Expression Technology™ platform based on the microorganism, Pseudomonas fluorescens, for the production of research proteins, reagent proteins, biosimilars and innovator biopharmaceuticals. For more information please visit www.pfenex.com


'/>"/>
SOURCE Pfenex Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. OptiScan Biomedical Presents Study Results Demonstrating OptiScanners Excellent Glucose Monitoring Accuracy in Critically Ill ICU Patients
2. Biospace Lab and the Centre for Advanced Biomedical Imaging at University College London to Collaborate on Development of Novel Real-Time in Vivo Optical Imaging Technologies
3. What Recession? How Biomedical Device Companies Thrived in a Bad Economy
4. Crux Biomedicals IVC Filter Receives CE Mark Approval
5. HealthTech Capital Leads Series A2 With Over $300,000 Investment in Cadence Biomedical
6. Survey of Biomedical Industry CEOs Finds Lack of Investment and Regulatory Environment Threaten Future Growth and Innovation
7. Pepex Biomedical Signs Seven Year Deal to Manufacture "Trio™"
8. Saladax Biomedical, Inc. Expands Distribution of My5-FU in Europe
9. Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations
10. U.S. Biomedical Leaders Present Leaders on Capitol Hill with New National Strategy for Innovation
11. Saladax Biomedical, Inc. Names Edward Chu, M.D., Chair of the Companys Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/11/2019)... ... 2019 , ... A new study published today in JAMA ... identity from transgender to cisgender is associated with a range of adverse mental ... Fenway Institute, Massachusetts General Hospital (Harvard Medical School), and McLean Hospital (Harvard Medical ...
(Date:9/11/2019)... ... September 11, 2019 , ... ... a period of rediscovery and attraction from big pharma, nutraceutical manufacturers, food companies, ... and North American use rates are expected to rise as access to hemp-derived ...
(Date:9/11/2019)... (PRWEB) , ... September 11, 2019 , ... ... today announced that elder care innovator HomeThrive has selected LifePod’s voice-first service for ... as unpaid caregivers to adults over the age of 50, demand has steadily ...
Breaking Medicine Technology:
(Date:9/11/2019)... ... September 11, 2019 , ... Autopsies don’t lie. They report the ... body. , Methamphetamine permanently harms the heart. It increases risks of heart attack ... understanding of how the damage occurs. , An August 1, 2019 article ...
(Date:9/11/2019)... ... September 11, 2019 , ... Executives at health systems ... change in the healthcare industry over the past several years has been intense. For ... The future of healthcare in America will depend largely on how these executives respond. ...
(Date:9/11/2019)... ... September 10, 2019 , ... Four Shriners for ... physicians have been recognized among the best doctors in the San Gabriel Valley ... Robert H. Cho, M.D. – Chief of Staff, scoliosis, spinal deformity ...
(Date:9/11/2019)... ... ... Dimensional Insight®, a data management, analytics and performance management company, ... Boston. To be held on Saturday, Sept. 28 on the Boston Common, the event ... St. Jude Children’s Research Hospital®. , “At Dimensional Insight, we believe that ...
(Date:9/9/2019)... ... September 09, 2019 , ... ... recently attended the American Association of Dental Office Management (AADOM) Annual Conference. This ... the Year (PAOY) award. This is Sharon’s third nomination in a row. The ...
Breaking Medicine News(10 mins):